Continuum Advisory, LLC Amgen Inc Transaction History

Continuum Advisory, LLC

  • $778 Million
  • Q3 2024

A detailed history of Continuum Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 5,119 shares of AMGN stock, worth $1.43 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,119
Previous 4,499 13.78%
Holding current value
$1.43 Million
Previous $1.41 Million 17.37%
% of portfolio
0.21%
Previous 0.21%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$309.38 - $337.38 $191,815 - $209,175
620 Added 13.78%
5,119 $1.65 Million
Q2 2024

Jul 19, 2024
BUY
$262.75 - $319.31 $3,415 - $4,151
13 Added 0.29%
4,499 $1.41 Million
Q1 2024

May 10, 2024
SELL
$268.87 - $324.56 $224,775 - $271,332
-836 Reduced 15.71%
4,486 $1.28 Million
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $252,375 - $284,710
987 Added 22.77%
5,322 $1.53 Million
Q3 2023

Nov 13, 2023
BUY
$218.65 - $271.46 $292,991 - $363,756
1,340 Added 44.74%
4,335 $1.17 Million
Q2 2023

Dec 13, 2023
SELL
$214.27 - $253.37 $24,426 - $28,884
-114 Reduced 3.67%
2,995 $664,000
Q2 2023

Aug 10, 2023
SELL
$214.27 - $253.37 $24,426 - $28,884
-114 Reduced 3.67%
2,995 $664,000
Q1 2023

Dec 13, 2023
BUY
$225.79 - $275.2 $22,804 - $27,795
101 Added 3.36%
3,109 $751,000
Q1 2023

May 12, 2023
BUY
$225.79 - $275.2 $22,804 - $27,795
101 Added 3.36%
3,109 $751,000
Q4 2022

Dec 13, 2023
BUY
$229.03 - $291.01 $57,944 - $73,625
253 Added 9.18%
3,008 $790,000
Q4 2022

Feb 10, 2023
BUY
$229.03 - $291.01 $57,944 - $73,625
253 Added 9.18%
3,008 $790,000
Q3 2022

Dec 13, 2023
SELL
$224.46 - $253.15 $9,427 - $10,632
-42 Reduced 1.5%
2,755 $620,000
Q3 2022

Nov 08, 2022
SELL
$224.46 - $253.15 $9,427 - $10,632
-42 Reduced 1.5%
2,755 $621,000
Q2 2022

Dec 13, 2023
BUY
$230.71 - $256.74 $47,295 - $52,631
205 Added 7.91%
2,797 $680,000
Q2 2022

Aug 15, 2022
BUY
$230.71 - $256.74 $47,295 - $52,631
205 Added 7.91%
2,797 $681,000
Q1 2022

Dec 13, 2023
BUY
$219.27 - $242.57 $200,193 - $221,466
913 Added 54.38%
2,592 $626,000
Q1 2022

May 17, 2022
BUY
$219.27 - $242.57 $200,193 - $221,466
913 Added 54.38%
2,592 $604,000
Q4 2021

Dec 13, 2023
SELL
$198.88 - $227.6 $117,538 - $134,511
-591 Reduced 26.04%
1,679 $377,000
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $117,538 - $134,511
-591 Reduced 26.04%
1,679 $378,000
Q3 2021

Dec 13, 2023
BUY
$212.27 - $248.7 $90,639 - $106,194
427 Added 23.17%
2,270 $482,000
Q3 2021

Nov 08, 2021
BUY
$212.27 - $248.7 $90,639 - $106,194
427 Added 23.17%
2,270 $483,000
Q2 2021

Dec 13, 2023
SELL
$233.58 - $259.14 $582,081 - $645,776
-2,492 Reduced 57.49%
1,843 $449,000
Q2 2021

Aug 17, 2021
BUY
$233.58 - $259.14 $430,487 - $477,595
1,843 New
1,843 $449,000
Q3 2020

May 17, 2021
SELL
$234.65 - $260.95 $201,095 - $223,634
-857 Closed
0 $0
Q2 2020

May 18, 2021
BUY
$197.81 - $242.74 $169,523 - $208,028
857 New
857 $219,000
Q1 2019

May 18, 2021
SELL
$180.87 - $203.88 $252,132 - $284,208
-1,394 Closed
0 $0
Q4 2018

May 18, 2021
SELL
$178.4 - $208.25 $40,496 - $47,272
-227 Reduced 14.0%
1,394 $271,000
Q3 2018

May 18, 2021
SELL
$185.29 - $208.89 $166,205 - $187,374
-897 Reduced 35.62%
1,621 $335,000
Q2 2018

May 18, 2021
SELL
$166.05 - $186.51 $13,284 - $14,920
-80 Reduced 3.08%
2,518 $465,000
Q1 2018

May 18, 2021
SELL
$169.43 - $198.0 $234,999 - $274,626
-1,387 Reduced 34.81%
2,598 $443,000
Q4 2017

May 18, 2021
BUY
$168.79 - $188.59 $18,735 - $20,933
111 Added 2.87%
3,985 $693,000
Q3 2017

May 18, 2021
SELL
$167.29 - $191.0 $11,041 - $12,606
-66 Reduced 1.68%
3,874 $722,000
Q2 2017

May 18, 2021
BUY
N/A
737 Added 23.01%
3,940 $679,000
Q1 2017

May 18, 2021
BUY
N/A
3,203
3,203 $526,000

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email